Identifying high‐risk medications and error types in Danish patient safety database using disproportionality analysis

Background Medication error (ME) surveillance in Danish healthcare relies on the mandatory national incident reporting system, the Danish Patient Safety Database (DPSD). Individual case reviews and descriptive statistics with frequency counts are the most often used approaches when analyzing MEs in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacoepidemiology and drug safety 2024-02, Vol.33 (2), p.e5735-n/a
Hauptverfasser: Tchijevitch, Olga, Birkeland, Søren F., Bogh, Søren B., Hallas, Jesper
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Medication error (ME) surveillance in Danish healthcare relies on the mandatory national incident reporting system, the Danish Patient Safety Database (DPSD). Individual case reviews and descriptive statistics with frequency counts are the most often used approaches when analyzing MEs in incident reporting systems, including the DPSD. However, incident reporting systems often generate a large number of reports and may suffer from underreporting; consequently, additional approaches are needed to overcome these challenges. Disproportionality analysis (DPA) is a statistical tool used for signal detection of adverse drug reactions in pharmacovigilance reports, but the evidence for using DPA on ME analysis in safety reporting systems is limited. Objectives We aimed to test the feasibility of DPA by analysing harmful MEs reported to DPSD 2014–2018. Methods We utilized proportional reporting ratios (PRR) to identify signals of diproportionality. Results We identified well‐known high‐risk medicines, including anticoagulants, opioids, insulins, antiepileptic, and antipsychotic drugs, and their association with several ME types and stages in a medication process. Conclusion DPA might be suggested as an additional tool for screening MEs and identifying priority areas for further investigation in safety reporting systems.
ISSN:1053-8569
1099-1557
1099-1557
DOI:10.1002/pds.5735